Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Hydromorphone Hydrochloride Injection
Status: Currently in Shortage
»Date first posted:
10/31/2017
»Therapeutic Categories: Analgesia/Addiction
Fresenius Kabi USA, LLC (Reverified 09/04/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 1 mg/1 mL (NDC 63323-852-25) | Unavailable | Backordered. Next release September 2024. Check wholesaler for inventory. | Demand increase for the drug |
| Injection, 2 mg/1 mL (NDC 63323-853-25) | Unavailable | Backordered. Next release September 2024; Check wholesalers for inventory | Demand increase for the drug |
| Injection, 4 mg/1 mL (NDC 63323-854-10) | Available | Check wholesalers for inventory | |
| Injection, 10 mg/1 mL (NDC 63323-851-10) | Unavailable | Backordered. Next release September 2024. Check wholesalers for inventory. | Demand increase for the drug |
| Injection, 10 mg/1 mL (NDC 63323-851-15) | Unavailable | Backordered. Next release August 2024; Check wholesalers for inventory. | Delay in shipping of the drug |
| Injection, 10 mg/1 mL (NDC 63323-851-50) | Unavailable | Backordered. Next release not available at this time. Check wholesaler for inventory. | Demand increase for the drug |
| Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11) | Unavailable | Backordered. Next release September 2024. Check wholesaler for inventory. | Demand increase for the drug |
| Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11) | Available | Check wholesalers for inventory | |
| Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11) | Unavailable | Backordered. Next release not available at this time. Check wholesaler for inventory. | Demand increase for the drug |
| Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06) | Unavailable | Backordered. Next release August 2024. Check wholesalers for inventory. | Demand increase for the drug |
Hikma Pharmaceuticals USA, Inc. (Reverified 08/28/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Hydromorphone HCl Injection, USP, Injection, 2 mg/1 mL (NDC 0641-0121-25) | Available | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | |
| Hydromorphone HCl Injection, USP, Injection, 2 mg/1 mL (NDC 0641-2341-41) | Available | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. |
Hospira, Inc., a Pfizer Company (Revised 08/26/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 2 mg/1 mL (NDC 0409-3365-10) | Unavailable | Next Delivery: January 2025; Estimated Recovery: March 2025 | Delay in shipping of the drug |
| Injection, 1 mg/1 mL (NDC 0409-1283-37) | Unavailable | Next Delivery: October 2024; Estimated Recovery: December 2024 | Delay in shipping of the drug |
| Injection, 2 mg/1 mL (NDC 0409-1312-36) | Unavailable | Next Delivery: November 2024; Estimated Recovery: December 2024 | Delay in shipping of the drug |
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31) | Limited Availability | Limited Supply Available; Estimated Recovery: December 2024 | Other |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30) | Limited Availability | Limited Supply Available; Estimated Recovery: September 2024 | Other |
| Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31) | Available | ||
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-2552-01) | Unavailable | Next Delivery and Estimated Recovery: June 2025 | Other |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01) | Unavailable | Next Delivery: January 2025; Estimated Recovery: March 2025 | Other |
| Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05) | Unavailable | Next Delivery: January 2025; Estimated Recovery: March 2025 | Other |
| Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50) | Unavailable | Next Delivery: January 2025; Estimated Recovery: March 2025 | Other |
Teva Pharmaceuticals USA, Inc. (Revised 08/23/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Hydromorphone Hydrochloride Injection, USP CII, Injection, 10 mg/1 mL (NDC 0703-0110-03) | Unavailable | Estimated recovery TBD | Demand increase for the drug |
| Hydromorphone Hydrochloride Injection, USP CII, Injection, 10 mg/1 mL (NDC 0703-0113-03) | Unavailable | Estimated recovery TBD | Demand increase for the drug |
| Hydromorphone Hydrochloride Injection, USP CII, Injection, 10 mg/1 mL (NDC 0703-0018-01) | Unavailable | Estimated recovery TBD | Other |